Company / Current Liabilities
FENNEC PHARMACEUTICALS INC. Current Liabilities History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$10.5M
FY2025
5-year range
$1.7M / $10.5M
FY2021-FY2025
Trend
+52.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 10 years, ranging from $402,000 in FY2016 to $11M in FY2025.
Based on SEC 10-K filings.
$11M in FY2025 with a 10-year CAGR of +36.4%.
Increased from $8M to $11M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +36.4%
Key checks
Key Insights
- In FY2025, current liabilities increased 52.0% year-over-year.
- Lowest current liabilities in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.5M | +52.0% |
| FY2024 | $6.9M | -8.4% |
| FY2023 | $7.6M | +356.7% |
| FY2021 | $1.7M | -27.2% |
| FY2019 | $2.3M | +38.7% |
| FY2018 | $1.6M | -0.4% |
| FY2017 | $1.6M | +309.0% |
| FY2016 | $402.0K | -14.6% |
| FY2015 | $471.0K | -73.2% |
| FY2014 | $1.8M | -45.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026